MLLT3 and acute myeloid leukemia: Importantly, mice in the MLL-AF9 + miR-550-1 group exhibited a significantly longer latency for AML development as compared with either the control group or the MLL-AF9 + miR-550-1 mutant group (both P<0.05; Fig.4H).